Skip to Content

Xulane Approval History

FDA Approved: Yes (First approved April 16, 2014)
Brand name: Xulane
Generic name: ethinyl estradiol and norelgestromin
Dosage form: Transdermal System
Company: Mylan Pharmaceuticals Inc.
Treatment for: Birth Control

Xulane (ethinyl estradiol and norelgestromin transermal system) is a generic version of Ortho Evra, a birth control patch used to prevent pregnancy.

Development History and FDA Approval Process for Xulane

DateArticle
Apr 18, 2014Approval Mylan Launches Xulane - First Generic Ortho Evra Patch

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide